1729 related articles for article (PubMed ID: 33543942)
1. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
3. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
5. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
6. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
7. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis and review examining a possible role for oxidative stress and singlet oxygen in diverse diseases.
Petrou AL; Terzidaki A
Biochem J; 2017 Aug; 474(16):2713-2731. PubMed ID: 28768713
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
Choi ML; Gandhi S
FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
[TBL] [Abstract][Full Text] [Related]
11. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
12. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of Disordered Proteins Associated with Neurodegeneration.
Tsoi PS; Quan MD; Ferreon JC; Ferreon ACM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834792
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
16. Misfolded proteins in Alzheimer's disease and type II diabetes.
DeToma AS; Salamekh S; Ramamoorthy A; Lim MH
Chem Soc Rev; 2012 Jan; 41(2):608-21. PubMed ID: 21818468
[TBL] [Abstract][Full Text] [Related]
17. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
Candreva J; Chau E; Rice ME; Kim JR
Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome.
Masters SL; O'Neill LA
Trends Mol Med; 2011 May; 17(5):276-82. PubMed ID: 21376667
[TBL] [Abstract][Full Text] [Related]
20. Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Bonito-Oliva A; Barbash S; Sakmar TP; Graham WV
Sci Rep; 2017 Feb; 7():42880. PubMed ID: 28220836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]